Selective alterations of brain dopamine D2 receptor binding in cirrhotic patients: Results of a 11C-N-methylspiperone PET study

Metabolic Brain Disease

Volumn 23, Issue 3, 2008, Pages 265-274

  Watanabe, Yuki ^a   Kato, Akinobu ^b   Sawara, Kei ^a   Butterworth, Roger F ^c   Sasaki, Toshiaki ^a   Terasaki, Kazunori ^a   Sera, Koichiro ^a   Suzuki, Kazuyuki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b Morioka Municipal Hospital   (Japan)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

11C N methylspiperone; Alcohol dependency; Dopamine D2 receptor; Hepatic encephalopathy; Liver cirrhosis; Positron emission tomography

Indexed keywords

3 METHYLSPIPERONE C 11; BRAIN RECEPTOR; DOPAMINE 2 RECEPTOR;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ALCOHOLISM; ARTICLE; BILIRUBIN BLOOD LEVEL; BINDING ASSAY; BINDING SITE; BRAIN NUCLEUS; BRAIN REGION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; FEMALE; HEPATIC ENCEPHALOPATHY; HIPPOCAMPUS; HUMAN; LIGAND BINDING; LIVER CIRRHOSIS; LIVER FAILURE; MALE; MOTOR DYSFUNCTION; NEUROLOGICAL COMPLICATION; POSITRON EMISSION TOMOGRAPHY; PROTHROMBIN TIME; QUANTITATIVE ASSAY; RECEPTOR BINDING; RISK FACTOR; SCORING SYSTEM; THALAMUS;

ADULT; AGED; ANALYSIS OF VARIANCE; BRAIN; BRAIN CHEMISTRY; FEMALE; HUMANS; LINEAR MODELS; LIVER CIRRHOSIS; LIVER CIRRHOSIS, ALCOHOLIC; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTORS, DOPAMINE D2; SPIPERONE;

EID: 50049100332     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11011-008-9092-7     Document Type: Article

References (16)

1. Audet R, Butterworth, F (1998) Portacaval anastomosis results in more severe neurological impairment and more widespread reductions in cerebral metabolism in old versus young adult rats: implications for post-TIPS encephalopathy. Metab Brain Dis 13(1):69-78
2. Bergeron M, Reader TA, Pomier-Layrargues G, Butterworth RF (1989) Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurochem Res 14:853-859
3. Ebert D, Klein T, Lohrmann C, van Elst T, Hesslinger B, Juengling FD (2002) Different striatal dopamine D2 receptor occupancy in alcohol dependent patients with or without physical withdrawal symptoms-a study using IBZM-SPECT. J Neural Transm 109:1215-1219
4. Finch CE, Roth GS (1999) Biochemistry of aging. In: Siegel GJ (ed) Basic neurochemistry: molecular, cellular and medical aspects. 6th edn. Lippincott-Raven, Philadelphia, pp 614-625
5. Hanje AJ, Patel T (2007) Preoperative evaluation of patients with liver disease. Nat Clin Pract Gastroenterol Hepatol 4:266-276
6. Heinz A, Siessmeier T, Wrase J, Hermann D, Klein S, Grusser M, Flor H, Braus DF, Buchholz HG, Grunder G, Schreckenberger M, Smolka N, Rosch F, Mann K, Bartenstein P (2004) Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving. Am J Psychiatry 161:1783-1789
7. Lockwood AH, Yap EW, Rhoades HM, Wong WH (1991) Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy. J Cereb Blood Flow Metab 11(2):331-336
8. Lunzer M, James IM, Weinman J, Sherlock S (1974) Treatment of chronic hepatic encephalopathy with levodopa. Gut 15:555-561
9. Morgan MY, Jakobovits AW, James IM, Sherlock S (1980) Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology 78(4):663-670
10. Mousseau DD, Perney P, Pomier-Layrargues G, Butterworth RF (1993) Selective loss of pallidal dopamine D2 receptor density in hepatic encephalopathy. Neurosci Lett 162:192-196
11. Mousseau DD, Baker GB, Butterworth RF (1997) Increased density of catalytic sites and expression of brain monoamine oxidase A in humans with hepatic encephalopathy. J Neurochem 68:1200-1208
12. Pomier-Layrargues G, Spahr L, Butterworth RF (1995) Increased manganese concentrations in pallidum of cirrhotic patients: cause of magnetic resonance hyperintensity? Lancet 345:735
13. Spahr L, Butterworth RF, Fontaine S, Bui L, Therrien G, Milette PC, Lebrun LH, Zayed J, Leblanc A, Pomier-Layrargues G (1996) Increased blood manganese in cirrhotic patients: relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms. Hepatology 24:1116-1120
14. Takeuchi R, Yonekura Y, Matsuda H, Konishi J (2002) Usefulness of a three-dimensional stereotaxic ROI template on anatomically standardized 99mTc-ECD SPET. Eur J Nucl Med Mol Imaging 29:331-341
15. Weissenborn K, Kolbe H (1998) The basal ganglia and portal-systemic encephalopathy. Metab Brain Dis 13:261-272
16. Weissenborn K, Berding G, Kostler H (2000) Altered striatal dopamine D2 receptor density and dopamine transport in a patient with hepatic encephalopathy. Metab Brain Dis 15:173-178